I see no way that Celldex does not either A) get acquired or B) trade significantly higher.
Up until this point, most, if not all, of its one-year 280% gains has been related to the survival data from its breast cancer drug. But luckily, the company has another Phase 3 drug that has flown under-the-radar, a product that should be dominating all the headlines within the next few months, rindopepimut. Hence, I say this rally is not even close to being over.
Is it even a "rally" or just steady, continuous, healthy growth? Up around 6% over the last 5 days and -- if you cut out Friday which was probably somewhat anomalous given a Friday after a holiday (I think a lot of stocks saw unusual activity that day) -- there is just a continuous smooth line of ascent. We do shoot up every now and then, but, after some leveling off there is just the nice, healthy, regular increase that has been CLDX's growth patter for over a year. Where we're going fireworks aren't even necessary now (though fun); we (longs) are just persistently reminded we are going in the right direction in the long run
yuup , i just got back in when it looked like it was done bleeding , got some nov 25s , got home & saw the article ..got me a little tsrx & halo ...paid for with cldx...been a huge win for me . got aug 12s back when it broke outta 9.5 range for 50 cents & sold em all for 8 - 8.9 when it hit 21.